p38MAPKa Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

The authors showed that p38MAPKa inhibition limited tumor growth by reprograming the metastatic tumor microenvironment in a CD4+ T cell, IFNy, and macrophage dependent manner.
[Cancer Discovery]
Full ArticlePress Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News